Regeneron’s third quarter results were well received by the market, reflecting strong execution in its commercial portfolio and key products. Management attributed the positive momentum to ...

A patient dosed with Intellia Therapeutics’ CRISPR gene therapy has died after suffering a severe liver-associated adverse ...

No Notifications Policy “I don’t have notifications,” Dimon told CNN’s Erin Burnett. “If you sent me a text during the day, I probably do not read it.” The only people ...

Awaiting FDA clinical hold letter on MAGNITUDE and MAGNITUDE-2 clinical trials of nex-zPresenting longer-term Phase 1 ...

Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the ...

The pharma giant disclosed in an earnings report that it paid $170 million up front to acquire SixPeaks Bio, a weight loss-focused startup it helped launch last year.

DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI Healthcare") today announced its financial results for the quarter ended September 30, 2025. DRI Healthcare's third quarter 2025 financial ...

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today reported its consolidated financial results for the third quarter ended September 30, 2025 and reviewed ...

German dialysis specialist Fresenius Medical Care (FMC) said on Tuesday that Chief Executive Rice Powell would retire to be succeeded by Carla Kriwet on Jan. 1.

AstraZeneca Plc (AZN.L)'s head of oncology research, Jose Baselga, has died at the age of 61, the company said on Sunday.